Home  /  Resource Library  /  Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Phase 1b dose-escalation study

Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Phase 1b dose-escalation study

Results of a study investigating glofitamab combined with chemoimmunotherapy for treatment of relapsed lymphomas.